| Product Code: ETC13161342 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Prophylactic Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Prophylactic Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Africa Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.9 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Africa Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Africa Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Prophylactic Vaccines Market Trends |
6 Africa Prophylactic Vaccines Market, 2021 - 2031 |
6.1 Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Live/Attenuated Vaccines, 2021 - 2031 |
6.1.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Inactivated Vaccines, 2021 - 2031 |
6.1.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Subunit Vaccines, 2021 - 2031 |
6.1.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Toxoid Vaccines, 2021 - 2031 |
6.1.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Conjugate Vaccines, 2021 - 2031 |
6.1.7 Africa Prophylactic Vaccines Market, Revenues & Volume, By Recombinant Vector Vaccines, 2021 - 2031 |
6.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Pneumococcal Disease, 2021 - 2031 |
6.2.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Poliovirus, 2021 - 2031 |
6.2.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.2.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Measles, 2021 - 2031 |
6.2.7 Africa Prophylactic Vaccines Market, Revenues & Volume, By Mumps, 2021 - 2031 |
6.2.8 Africa Prophylactic Vaccines Market, Revenues & Volume, By Rubella (MMR), 2021 - 2031 |
6.2.9 Africa Prophylactic Vaccines Market, Revenues & Volume, By Varicella, 2021 - 2031 |
6.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Intramuscular Route, 2021 - 2031 |
6.3.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Subcutaneous Route, 2021 - 2031 |
6.3.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Oral Route, 2021 - 2031 |
6.3.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Intravenous Injection, 2021 - 2031 |
6.3.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration Routes, 2021 - 2031 |
6.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021 - 2031 |
6.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
7 Africa Prophylactic Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
7.3.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Africa Prophylactic Vaccines Market Key Performance Indicators |
9 Africa Prophylactic Vaccines Market - Export/Import By Countries Assessment |
10 Africa Prophylactic Vaccines Market - Opportunity Assessment |
10.1 Africa Prophylactic Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
10.4 Africa Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
10.5 Africa Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.6 Africa Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 Africa Prophylactic Vaccines Market - Competitive Landscape |
11.1 Africa Prophylactic Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Africa Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here